A not entirely unrelated and decent sized partnership event reported in the media:
https://www.fiercebiotech.com/biotech/light-horse-ropes-novartis-partnership-worth-1b-wrangles-62m-series
There have been a few recently improving the backdrop for IMU's partnership prospects:
https://www.globenewswire.com/news-release/2025/01/06/3004469/0/en/CytoMed-Therapeutics-signs-Business-Research-Collaboration-Agreement-with-India-s-SunAct-Cancer-Institute-Private-Limited-to-advance-use-of-allogeneic-off-the-shelf-Gamma-Delta-T-C.html
https://www.prnewswire.com/news-releases/poseida-therapeutics-announces-nomination-of-new-car-t-development-candidate-under-collaboration-with-roche-302278768.html
https://multiplesclerosisnewstoday.com/news-posts/2024/12/02/roche-buy-poseida-building-car-t-cell-collaboration/
https://www.genengnews.com/gen-edge/novartis-ptc-ink-up-to-2-9b-huntingtons-disease-collaboration/
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 5795292 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3258567 | 9 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |